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aBSTRaCT
BaCKGROund: Fetuin-A is a negative acute-phase reactant which prevents vascular calcification. 
Coronary artery disease (CAD) is the most important cause of mortality in patients undergoing renal 
replacement therapy (RRT). The key element of cardiovascular disease (CVD) seen in end-stage renal 
disease patients who are on dialysis treatment is accelerated calcific atherosclerosis. There are a limited 
number of studies in which HD and PD is compared in terms of fetuin-A level.
OBJECTıVE:  We  aimed  to  investigate  the  association  of  serum  fetuin-A  level  with  valvular 
calcification and predictors of CAD in hemodialysis (HD) and peritoneal dialysis (PD) patients. 
maTERıal	and	mETHOdS: 39 HD (24 males, 15 females) and 39 PD (25 males, 14 females) 
patients were included in the study. We determined carotid artery intima media thickness (CIMT) and 
evaluated heart valve calcification via echocardiography. We also measured serum fetuin-A level, CRP, 
ferritin, fibrinogen and serum albumin level. According to fetuin-A level, patients were stratified into 
quartiles. 
RESulTS: Fetuin-A level was significantly lower in HD patients when compared with that of PD 
patients (28.6±5.934 ng/ml, 32±4.8 ng/ml respectively p<0.001). There was a significant negative 
correlation between CIMT and fetuin-A level. CIMT was found to be lower in PD patients than in HD 
patients. We found a positive correlation between fetuin-A and dialysis adequacy and albumin level. 
There was a negative correlation of fetuin-A with age, fibrinogen, ferritin and CRP. Fetuin-A level was 
lower in patients with aortic calcification. 
COnCluSıOn: Fetuin-A level was found to be lower in HD patients. Fetuin-A may be a novel marker 
for CVD in patients undergoing RRT. 
KEY	wORdS: Calcification, Fetuin-A, Hemodialysis, Intima media thickness, Peritoneal dialysis
öz
GİRİş: Fetuin A vasküler kalsifikasyonu önleyen bir negatif akut faz reaktanıdır. Koroner arter hastalığı 
(KAH) renal replasman tedavisi almakta olan hastalarda en önemli ölüm sebebidir. Diyalize giren son 
dönem  böbrek  yetmezliği  hastalarında  görülen  kardiyovasküler  hastalığın  ana  elementi  hızlanmış 
kalsifik aterosklerozdur. Fetuin A seviyeleri açısından hemodiyaliz (HD) ve periton diyalizini(PD) 
karşılaştıran sınırlı sayıda çalışma mevcuttur. 
amaÇ:  HD  ve  PD  hastalarında  KAH  prediktörleri  ve  valvüler  kalsifikasyon  ile  serum  fetuin A 
düzeyleri arasındaki ilişkiyi araştırmayı amaçladık. 
GEREÇ	ve	YönTEmlER: 39 HD (24 erkek, 15 kadın) ve 39 PD (25 erkek, 14 kadın) hastası 
çalışmaya  alındı.  Karotis  intima  media  kalınlığı  (KIMK)  ultrason  ile  ölçüldü  ve  kalp  kapağı 
kalsifikasyonları ekokardiyografi ile değerlendirildi. Ayrıca serum fetuin-A, CRP, ferritin, fibrinojen, 
ve albumin seviyeleri saptandı. Fetuin-A düzeylerine göre hastalar çeyreklere ayrıldı. 
BulGulaR:	Fetuin-A seviyesi HD hastalarında PD hastalarına göre daha düşüktü (hemodiyaliz 
28,6±5,934 ng/ml, PD 32±4,8 ng/ml, p<0,001). KIMK ile fetuin-A seviyesi arasında anlamlı negatif 
korelasyon  vardı.  KIMK,  PD  hastalarında  HD’e  göre  daha  düşüktü.  Fetuin-A  seviyesi  ile  diyaliz 
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In this present study, we aimed to investigate the relation 
of fetuin-A with valvular calcification and predictors of CVD 
(CIMT, MIA syndrome, Inflammatory parameters) in patients 
who had been on HD or PD for more than 6 months and had no 
signs or symptoms of CVD. We also evaluated whether there 
was any difference between HD and PD with respect to these 
parameters.
maTERıal	and	mETHOdS
We included 39 HD and 39 PD patients who were being 
followed at our dialysis center. Local ethics committee approved 
study protocol and all participants of the study signed informed 
consent  forms.  Duration  of  dialysis,  demographic  data  and 
medications of patients were recorded.
Exclusion  criteria  of  the  study  were  as  follows;  dialysis 
therapy  for  less  than  6  months,  malignity,  serious  trauma, 
surgical operation or burn during the last 1 month, presence of 
active infectious disease, clinically evident CVD (evidence of 
previous myocardial infarction findings in ECG, specific anginal 
pain,  previous  coronary  by-pass  operation  or  percutanous 
coronary intervention and peripheral arterial disease), chronic 
liver disease, hospitalization of any cause during the last three 
months, peritonitis during the last three months.
Carotid  ultrasonography  and  echocardiography:  Echocar-
diography and carotid artery evaluations were performed by an 
experienced cardiologist who was blinded to treatment status, 
clinical and laboratory data of study patients. Each evaluation 
was performed between 08.00 -11.00 AM, at least after 15 min-
utes rest. CIMT was measured at approximately 10 mm proxi-
mal to carotid artery bifurcation of two carotid arteries. Mean 
CIMT value was reached as calculating arithmetic mean of mea-
surements of two carotid arteries. In addition, heart valve calci-
fication was evaluated by means of echocardiography. 
Biochemical	analyses
Blood  samples  were  collected  in  appropriate  tubes  and 
then centrifuged at 4000 rpm for 5 minutes and serums were 
separated. Measurement of fetuin-A level was performed via 
ELISA kit method. Serum samples were used to measure lipid 
parameters  (Lip  (a),  HDL,  total  cholesterol  and  triglyceride 
levels),  ferritin,  fibrinogen,  homocysteine,  electrolytes, 
albumin and CRP. Serum albumin analysis was performed with 
ınTROduCTıOn
When compared with the general population, cardiovascular 
disease  (CVD)  in  patients  with  end  stage  renal  disease 
(ESRD) is 10-20 times higher albeit recent developments in 
RRT (1). In addition to traditional risk factors (such as age, 
smoking, hypertension, dyslipidemia) some novel risk factors 
which  are  specific  to  ESRD  such  as  anemia,  proteinuria, 
hyperparathyroidism,  inflammation,  hyperhomocysteinemia, 
malnutrition and uremic toxins are responsible for the increased 
frequency of CVD in this population (2-3). Known traditional 
cardiovascular risk factors do not suffice solely to account for 
early  atherosclerosis  development  in  ESRD  patients.  Thus, 
novel risk factors which affect atherosclerosis development in 
ESRD patients should be identified. 
The key element of CVD seen in ESRD patients who are 
on  dialysis  treatment  is  accelerated  calcific  atherosclerosis. 
Previous studies reported increased frequency of coronary artery 
calcification even in younger dialysis patients (4). Other studies 
concluded  that  vascular  and  cardiac  valvular  calcifications 
were independent risk factors for CVD in dialysis patients (5-
6). In some experimental studies conducted in rats, a number 
of vascular calcification inhibitors such as fetuin-A, Matrix Gla 
Protein and osteoprotegerin have been elucidated. Fetuin-A was 
deemed as the most important one which constitutes 50% of 
total serum precipitation inhibiting capacity alone among these 
factors (7-8). 
Fetuin-A  is  a  circulating  serum  protein  with  a  molecular 
weight of approximately 60 kDa synthesized by hepatocytes 
reaching high serum concentrations (0.4–1.0 g/L). Fetuin-A is a 
negative acute phase reactant and represents a prominent part of 
the α2- band of serum electrophoresis.
Although it is not seen a significant decrease in fetuin-A level 
during HD, there seems to be a decrease in its level during PD 
in a similar fashion to that of albumin (9-10). Some investigators 
reported that fetuin-A deficiency was a more potent predictor of 
mortality in comparison to hypoalbuminemia and high serum 
CRP levels and was a key element of MIA syndrome (5-6). There 
are a limited number of studies in which HD and PD are compared 
in terms of fetuin-A level. Two previously conducted studies 
showed  that  fetuin-A  level  in  HD  patients  were  significantly 
lower when compared to that of PD patients (11-12). However, 
another study did not confirm these findings (13). 
yeterliliği ve albumin arasında pozitif korelasyon saptanırken fetuin-A ile yaş, fibrinojen, ferritin ve CRP arasında negatif korelasyon saptandı. 
Fetuin-A düzeyi aortik kalsifikasyonu olanlarda daha düşüktü (p<0.05). 
SOnuÇ: Fetuin-A seviyesi HD hastalarında daha düşük olarak saptandı. KAH prediktörleri ile ilişkisi düşünüldüğünde RRT almakta olan 
hastalarda özellikle HD hastalarında KVH için yeni bir belirteç olabilir. 
anaHTaR	SözCÜKlER: Fetuin-A, Hemodiyaliz, İntima media kalınlığı, Peritoneal diyaliz, Valvular kalsifikasyonSolak Y et al : Fetuin-A and Calcification in ESRD
Turk Neph Dial Transpl 2013; 22 (1): 52-59
54
Türk	nefroloji	diyaliz	ve	Transplantasyon	dergisi
Turkish Nephrology, Dialysis and Transplantation Journal
Statistical	analysis	
The  patients’  characteristics  were  presented  as  the  mean 
± SD. The student’s t-test for independent samples was used 
for normally distributed continuous variables, and the Mann-
Whitney U test was used for variables that were not normally 
distributed. Pearson correlation co-efficient was used to examine 
associations between two variables. Linearly associated 
parameters  with  fetuin-A  were  entered  in  the  multivariate 
linear regression model to determine the independent predictors 
of  fetuin-A.  Differences  among  categorical  variables  were 
analyzed using the chi-square test the level of significance was 
p < 0.05 for all comparisons. All calculations were performed 
using a standard statistical package (SPSS 13.0 for Windows).
RESulTS
Fetuin-a	and	demographic	characteristics	of	the	patients
When  all  patients  were  evaluated  according  to  dialysis 
type; HD and PD groups showed no difference in terms of age, 
time on dialysis, BMI, gender, smoking, frequency of diabetes 
mellitus and hypertension (p>0.05). Demographic and clinical 
characteristics of the patients are depicted in Table I. 
spectrophotometric Beckman Coulter Synchron LX Systems as 
using color reaction to bromocresol. Serum CRP analysis was 
performed  with  Beckman  Coulter  Synchron  LX  System  by 
using measurement of specific antigen-antibody complex which 
was formed by antigen-antibody reaction. Anticoagulated blood 
samples were used to analyze parathormone level; measurements 
were  performed  with  commercial  ELSA-PTH  kit  (CIS  Bio 
International, Yvette Cedex, France) using immunoradiometric 
gamma counter method.
Weight and height measurements of patients were performed 
after morning exchange when the patients’ peritoneal cavities 
were empty for PD patients and after midweek day HD session 
for  HD  patients.  BMI  was  calculated  using  BMI  (kg/m2) = 
Weight / (Height)2 equation.
MIA  Syndrome; (MIA  is  an  acronym which  was  created 
using  initials  of  malnutrution-Inflammation-atherosclerosis); 
we  considered  individual  components  of  the  syndrome  were 
fulfilled should serum albumin level <3.5 gr/dl (malnutrition), 
hs-CRP  level  >10  mg/dl  (Inflammation),  and  CIMT  >1mm 
(atherosclerosis).
Table	ı: Demographic and clinical characteristics of patients. 
Hd Pd P
male/Female	(n) 24/15 25/14 NS*
age	(years) 51.5 ± 14.4 50.2.4 ± 14.6 NS
dialysis	vintage	(months) 28.8 ± 21.1 27.0 ± 24.7 NS
Body	mass	index	(kg/m2) 26.7 ± 6.4 25.9 ± 4.1 NS
diabetes	mellitus	(n) 12 (%30.8) 11 (%28.2) NS
Hypertension	(n) 31 (%71.8) 32 (%82.1) NS
antihypertensive	drug	use	(n) 31 (%79.5) 36 (%92.3) NS
Smoking	(n) 7 (%17.9) 7 (%17.9) NS
Pulse	pressure	(mmHg) 46.6 ± 8.6 47.6 ± 7.7 NS
Systolic	blood	pressure	(mmHg) 124.3 ± 12.9 128.2 ± 16.0 NS
diastolic	blood	pressure	(mmHg) 77.6 ± 7.0 80.2.0 ± 10.6 NS
Fetuin-a	(ng/ml) 28.6 ± 5.9 34.2 ± 4.8 <0.001
Homocysteine	(µmol/l) 24.7 ± 8.6 20.3 ± 7.4 0.01
albumin	(gr/dl) 3.6 ± 0.3 3.7 ± 0.3 0.06
CRP	(mg/l) 14.1 ± 8.9 13.0 ± 10.1 NS
Ferritin	(ng/ml) 509.8 ± 251.9 355.3 ± 237.0 0.07
Fibrinogen	(mg/dl) 367.2 ± 74.1 430.1 ± 75.3 <0.001
Calcium	(mg/dl) 8.4 ± 0.4 8.7 ± 0.6 0.003
Ca	x	Phosphorus	(mg2/dl2) 41.2 ± 13.3 40.1 ± 10.2 NS
Parathormone	(pg/ml) 354.6 ± 272.8 460.5 ± 407.9 NS
Hemoglobin	(g/dl) 11.5 ± 1.5 11.5 ± 1.7 NS
Kt/V 1.28±0.18 2.45±0.88 <0.001
*nS:	Not Significant55
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  Fetuin-A  level  was  significantly  higher  in  PD  patients 
than that of HD patients (34.2 ± 4.8 ng/mL, 28.6 ± 5.9 ng/mL 
respectively, p<0.001). When fetuin-A levels were divided into 
4 quartiles, there were only 2 PD (5.1%) patients in contrast to 
19 HD (48.7%) patients in the first quartile (Table II). There 
was a negative correlation between fetuin-A and age (r=-0.26 
p=0.02). This correlation was due to the HD group (r= -0.37 P= 
0.01), and in fact there was no relation in the PD group (r= -0.05 
p= 0.76). Fetuin-A level was found to be significantly lower in 
diabetic patients (p= 0.01).
nutritional	parameters	and	fetuin-a
We did not find any significant difference between the two 
groups with respect to nutritional parameters. 23 HD patients 
Table	ıı: Distribution of HD and PD patients according to 
fetuin-A levels (ng/mL)
Fetuin	Quartiles
Hemodialysis
(n)
Peritoneal	
dialysis
(n)
Total
Quartile	1	(17.0-27.0) 19 2 21
Quartile	2	(27,1-32.0) 9 13 22
Quartile	3	(32,1-36.0) 7 11  18
Quartile	4	(36,1-50.0) 4 13  17 
Total 39 39 78
Figure 1: Relation between fetuin-A and CIMT in all patients (A) and HD patients (B) (r= -0.35 P= 0.01 and r= -0.30 P= 0.06, respectively)
a B
Figure 2: Relation between fetuin-A quartile and CIMT
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(Table III). When all patients were taken into account, patients 
who had aortic valve calcifications had significantly lower serum 
fetuin-A level (Figure 3). When aortic valve calcification were 
evaluated according to fetuin-A quartiles, only one patient had 
aortic valve calcification in the 4th quartile in which fetuin-A 
level was the highest (p=0.04). There was no difference between 
the groups in terms of aortic calcification. (p=0.1)
Fetuin-a,	inflammatory	markers	and	dialysis	adequacy	
There was a negative correlation between fetuin-A and CRP 
(r= -0.34 p= 0.002). This was also the case when HD and PD 
were evaluated separately. (r= -0.41 p= 0.008 and r= -0.36 p= 
0.02, respectively). Similarly there was a negative correlation 
between fetuin-A and fibrinogen (r= -0.24 p= 0.02) and this 
relation held true for both groups (HD: r= -0.42 p= 0.006, PD: 
r= -0.45 p= 0.003). There existed a negative correlation between 
fetuin-A and ferritin (r= -0.36 p= 0.001). However, when HD 
and  PD  were  evaluated  separately,  there  was  only  negative 
correlation in the HD group. (HD: r = -0.31 p= 0.04). We also 
found  a  positive  correlation  between  fetuin-A  and  dialysis 
adequacy (expressed as Kt/V) in whole patient population (r= 
0.29 p= 0.009). Linear regression analysis showed that age, Kt/V 
and CRP were independent predictors of fetuin-A (Table IV) 
had BMI greater than 25 kg/m2 whereas 22 PD patients had. 
Eight HD and 6 PD patients were hypoalbuminemic (p=0.6). 
Though not of statistical significance, there was a tendency for 
HD patients to have lower albumin level compared with PD 
patients (p=0.06) (Table I). There appeared a positive correlation 
of fetuin-A with albumin (r= 0.30 p= 0.006). When HD and 
PD  groups  were  evaluated  separately,  there  was  a  positive 
correlation between fetuin-A and serum albumin in HD patients 
whereas this was not the case in PD group (r= 0.33 p= 0.03, r= 
0.28 p= 0.08, respectively). 
Fetuin-a,	CımT,	and	calcification
Mean CIMT was greater in HD patients than in PD patients 
(1.54 ± 0.29 mm, 1.31 ± 0.24 mm respectively, p=0.001). There 
was a negative correlation between serum fetuin-A and CIMT 
(r= -0.35 p= 0.01). When each dialysis modality was evaluated 
separately, there was no relation between fetuin-A and CIMT 
(r= -0.30 p= 0.06, r=-0.1 p=0.6) (Figure 1A,B). While the CIMT 
of patients, who were in the first quartile (in which fetuin-A 
level was the lowest) was the greatest, CIMT of patients who 
were in the 4th quartile was the smallest and the difference was 
statistically significant (Figure 2). No difference was evident 
between the two groups with respect to valvular calcification 
Table	ııı: Fetuin A levels according to place and presence of valvular calcification.
aVC mVC aVC	veya	mVC P
Present
(n=18)
Absent
(n=60)
Present
(n=10)
Absent
(n=68)
Present
(n=22)
Absent
(n=56)
HD (n=39) 27.5 ±6.4 29.2 ±5.7 27.6 ±6.8 28.8 ±5.8 27.3 ±6.1 29.3 ±5.8 NS
PD (n=39) 31.3 ±4.4 34.7 ±4.8 34.8 ±2.8 34.1 ±5.1 33.0 ±4.3 34.6 ±5.0 NS
All patients (n=78) 28.7±5.9 32.2±5.9* 31.2 ±6.2 31.5 ±6.0 29.6 ±6.0 32.1 ±5.9 0.03
aVC: aortic valvular calcification, mVC: Mitral valvular calcification, Hd: hemodialysis patients, Pd:	peritoneal dialysis patients. 
*significant difference of fetuin-A levels in patients who had aortic valvular calcification., nS:	Not significant
Table	 ıV:  The  independent  predictors  of  fetuin-A  in 
multivariate linear regression model.
Variables Beta t P
Kt/V 1.713 2.57 0.01
CRP -0.20 -2.96 0.001
age -0.10 -2.35 0.02
Dialysis duration, Kt/V, Albumin, CRP, Age, Fibrinogen, ferritin 
and carotid intima media thickness were entered to multivariate 
linear regression model as an independent predictor of fetuin-A. 
The backward elimination method was used for the regression 
analysis. The remaining significant parameters are demonstrated 
in the table. Model R2=0.32, F=6.95 and model statistics P=0.001 
Table	V: Fetuin A levels according to numbers of components 
of MIA syndrome.
numbers	of	
components	of	mıa	
syndrome
numbers	of	
patients	(n)
Fetuin-a	
1 32 34.3 ± 5.3*.#
2 35 29.9 ± 4.0
3 11 27.8 ± 6.7
*: There is a significant difference between patients who had one 
component and two components (p<0.05)
#: There is a significant difference between patients who had one 
component and three components (p<0.05)57
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found a reverse relation between fetuin-A and AVC (P=0.03). 
However,  there  was  no  significant  relation  between  mitral 
valve calcification and fetuin-A. Among patients whose serum 
fetuin-A level >36.0 ng/mL, only one patient had AVC. Thus, we 
think that this value can be used as a cutoff for fetuin-A at which 
valvular calcification will be avoided. 
Moe et al. (24) reported that there was a negative correlation 
between  low  fetuin-A  level  and  coronary  calcification  and 
fetuin-A had an important role in the pathogenesis of coronary 
calcification. Another study involving 132 HD patients revealed 
a negative correlation between fetuin-A and coronary calcium 
scores which were measured by CT (14). To our opinion, when 
the findings of these two studies are taken together and findings 
regarding association of CIMT and valvular calcification with 
fetuin-A are taken into consideration, decreases in fetuin-A level 
of ESRD patients may be a potent predictor of CV mortality. 
In most of the studies investigating fetuin-A, it was reported 
that fetuin-A was related to Kt/V and CaXP product (11, 15). 
On the contrary, Coen et al. (14) reported a negative correlation 
between fetuin-A and Kt/V and CaXP product in 132 HD patients. 
Our study showed that there was a positive correlation between 
fetuin-A and Kt/V (r= 0.29 p= 0.009). However, there was no 
correlation between fetuin-A and CaXP product. A number of 
factors such as diet, dialysis adequacy, medications, secondary 
hyperparathyroidism,  can  affect  CaXP  product.  Because  of 
these confounding factors, it seems complex to evaluate the true 
relationship between fetuin-A and CaXP product. Association 
of  Kt/V  with  fetuin-A  is  clinically  important.  Because  this 
indicates that as providing adequate dialysis it seems possible to 
keep fetuin-A serum levels higher and to avoid untoward effects 
of low levels of fetuin-A. Multiple regression analysis showed 
that CRP, Kt/V and age were independent predictors of serum 
fetuin-A levels in ESRD patients. 
It is already known that the MIA syndrome was a determinant 
of  survival  of  ESRD  patients  and  patients  who  had  all 
components of MIA syndrome had a shorter survival rate (25). 
Wang et al. (23), in a study in which they investigated relation 
of fetuin-A with MIA syndrome and valvular calcification in 238 
PD patients, found that fetuin-A and valvular calcification were 
associated with the MIA syndrome and fetuin-A level was related 
to all clinical outcomes in PD patients. They also reported that 
the more the number of MIA syndrome components, the more 
fetuin-A level decreased and the greatest decrease in fetuin-A 
level was seen in patients who had all three components of MIA 
syndrome. Our findings were in agreement with that of Wang et 
al. (23).
Albumin is commonly used to evaluate the nutritional status 
of ESRD patients. It is known that patients with lower serum 
albumin had a higher prevalence of CVD (23, 26-27). Studies 
have shown that there was a positive correlation between serum 
fetuin-A level and albumin (7, 12,	23). We also confirmed this 
correlation in our study (r= 0.30 P= 0.006). 
Fetuin-a	and	components	of	mıa	Syndrome
There  was  no  statistically  significant  difference  between 
the  two  groups  in  terms  of  components  of  MIA  syndrome 
(Pearson Chi-Square = 4.07, p= 0.2). Regarding the relation 
of fetuin-A level with MIA syndrome; the more the number of 
the components of MIA, the lower the fetuin-A level (Table V). 
There was a significant difference between the patients who had 
one component of the MIA syndrome and patients who had 2 
or 3 components in terms of serum fetuin-A levels. (p=0.002 
and  p=0.007  respectively).  On  the  other  hand  there  was  no 
difference regarding serum fetuin-A level between the patients 
who had all three components of the MIA syndrome and who 
had two components (P= 0.4). Correlation between fetuin-A and 
CRP: in all patients, HD hemodialysis patients and PD patients 
was r= -0.34 p= 0.002, r= -0.41 p= 0.008 and r= -0.36 p= 0.02, 
respectively. 
dıSCuSSıOn
Our results showed that the fetuin-A level was lower in HD 
patients compared with PD patients and fetuin-A blood level 
was associated with major CAD predictors such as CIMT, aortic 
valve calcification (AVC), CRP, fibrinogen, albumin, dialysis 
adequacy  and  MIA  syndrome.  In  particular,  patients  whose 
serum fetuin-A level was ≤27.0 ng/mL had many of the poor 
prognostic markers which were inherent in ESRD patients. 
In studies investigating fetuin-A, serum fetuin-A level was 
found to be lower in ESRD patients compared to that of controls 
(13-15). However, limited data are available to compare HD 
and PD patients in terms of fetuin-A levels. Stenvinkel et al. 
(13) did not detect any significant difference between HD and 
PD patients with respect to serum fetuin-A. On the other hand, 
two other studies showed significantly lower levels of fetuin-A 
in HD patients when compared with PD patients (11-12). Our 
results also showed that HD patients had lower fetuin-A levels 
compared with PD patients (P=0.001). We think of that in the 
study by Stenvinkel et al. (13) duration of renal replacement 
therapies were relatively short (12 months), and this may be 
responsible for their failure to detect a difference between HD 
and PD in terms of serum fetuin-A level. 
CIMT is a strong predictor of mortality and cardiovascular 
events in ESRD patients (16-18). A strong negative correlation 
between fetuin-A and CIMT was reported in ESRD patients (19-
20). Similarly our study showed a negative correlation between 
serum fetuin-A level and CIMT. In particular, the patients in the 
first quartile whose serum fetuin-A were lower had increased 
CIMT  measurements  (1.6  mm).  In  our  opinion,  a  serum 
fetuin-A level ≤27.0 ng/mL can be considered a cutoff value for 
subclinical atherosclerosis. 
It was also shown that valvular calcification was an important 
predictor of all-cause and CV mortality in ESRD patients (6, 
14, 21-22). Wang et al. (23) reported lower fetuin-A levels in 
PD patients who had valvular calcification. In a similar vein we Solak Y et al : Fetuin-A and Calcification in ESRD
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ESRD is a chronic inflammatory state. Inflammatory markers, 
especially CRP, have been shown to be an independent predictor 
of mortality in HD and PD patients (26,	28). Association of 
increased CRP levels with cardiovascular mortality has been 
established for a long time. Most of the studies have shown a 
negative correlation between fetuin-A and CRP (7, 12, 23). In a 
similar way we also found a negative correlation between these 
parameters both in HD and PD groups (P= 0.002). There was a 
negative correlation between fetuin-A and other inflammatory 
markers, i.e., fibrinogen and ferritin as well. (p= 0.02, p= 0.001, 
respectively). 
Our  study  has  some  limitations;  our  sample  size  was 
relatively small. Since this is not a prospective controlled study 
we cannot draw cause and effect relations from our findings.
In conclusion, fetuin-A may be considered as a novel and 
important CVD risk marker because of its close relation with 
CAD predictors. Patients with a serum fetuin-A level ≤27.0 ng/
mL can be taken into consideration as a more risky group in 
terms of CVD. Considering that HD and PD do not confer an 
advantage over one another as to CVD risk, it can be suggested 
that fetuin-A can be helpful in evaluation of CVD risk, especially 
in HD patients. However, prospective randomized studies are 
needed to better evaluate the reliability of the fetuin-A cutoff 
value to predict cardiovascular events. 
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